Interleukin 1 and tumor necrosis factor-alpha synergistically increase the production of interleukin 6 in human synovial fibroblast

J Clin Lab Immunol. 1991 Mar;34(3):107-13.

Abstract

We have previously reported that synovial cells could participate in B cell differentiation processes in rheumatoid arthritis (RA) by producing interleukin-6 (IL-6) spontaneously or in response to interleukin-1 (IL-1) stimulation. In this paper, we examined the effects of tumor necrosis factor-alpha (TNF-alpha) on IL-6 production by human synovial fibroblasts. TNF-alpha, as well as IL-1, is a putative relevant molecule in the inflammatory process and in articular destruction in RA. Both IL-1 and TNF-alpha induced IL-6 production by synovial fibroblasts in a dose dependent manner. When synovial fibroblasts were stimulated by IL-1 and TNF-alpha in combination, IL-6 production increased synergistically after 48 hr of a 72 hr culture period. Kinetic studies revealed that the presence of both cytokines at the early phase of stimulation was required for the synergistic effect. These results suggest that TNF-alpha could be involved in a cytokine network in the affected joints of RA and could contribute synergistically with IL-1 to the IL-6 production by synovial fibroblasts in vivo.

MeSH terms

  • Arthritis, Rheumatoid / immunology
  • Cells, Cultured
  • Drug Synergism
  • Fibroblasts / cytology
  • Fibroblasts / immunology
  • Humans
  • Interleukin-1 / administration & dosage
  • Interleukin-1 / pharmacology*
  • Interleukin-6 / biosynthesis*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Synovial Membrane / cytology
  • Synovial Membrane / immunology
  • Tumor Necrosis Factor-alpha / administration & dosage
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Interleukin-1
  • Interleukin-6
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha